Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Invesco WilderHill Clean Energy ETF (PBW) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance

Invesco WilderHill Clean Energy ETFTrade
Royalty Pharma plc Class A Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Invesco WilderHill Clean Energy ETF vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Invesco WilderHill Clean Energy ETF trades at $28.29 (market cap $347.46M), while Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 72.7× Invesco WilderHill Clean Energy ETF's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Invesco WilderHill Clean Energy ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Invesco WilderHill Clean Energy ETF for 46 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.

PBWRPRX
Market Cap
$347.46M$25.27B
Volume
413,6983,671,183
Sector
Sector/ThematicHealth
52-Week High
$46.99$63.96
52-Week Low
$28.29$35.44
Typical Hold Time
46 Days0 Days
Enterprise Value
—$32.50B
Dividend Yield
—1.66%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Invesco WilderHill Clean Energy ETF

PBW, the Invesco WilderHill Clean Energy ETF, trades at $28.92, down 2.89% today amid a bearish technical signal from moving averages. The ETF's unique selection criteria prioritize ecological factors over financial metrics, resulting in concentrated exposure to the clean energy sector. Recent institutional selling, including a 96.3% reduction by IFP Advisors Inc. in Q2 2026 (SEC filing, September 18, 2026), reflects cautious sentiment despite long-term growth drivers like energy security and data center demand.

Outlook remains challenged by near-term volatility and sector underperformance versus broad markets, though global investment in clean energy offers structural tailwinds. Key risks include oil price swings, Fed policy impacts, and lack of diversification. Investors face a trade-off between speculative growth potential and elevated sensitivity to macroeconomic shifts.

Royalty Pharma plc Class A Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PBW
100% Buy0% Sell
Avg holding period · 46 Days
RPRX
100% Buy0% Sell
Avg holding period · 0 Days

About Invesco WilderHill Clean Energy ETF

PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.

Read more on PBW →

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.

Read more on RPRX →